You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
D-galactose Supplementation for the Treatment of Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE): A Pilot Trial of Precision Medicine After Epilepsy Surgery
|
|---|---|
| Published in |
Neurotherapeutics, June 2023
|
| DOI | 10.1007/s13311-023-01395-z |
| Pubmed ID | |
| Authors |
Ángel Aledo-Serrano, Adrián Valls-Carbó, Christina D Fenger, Gudrun Groeppel, Till Hartlieb, Irene Pascual, Erika Herraez, Borja Cabal, Irene García-Morales, Rafael Toledano, Marcelo Budke, Álvaro Beltran-Corbellini, Sara Baldassari, Roland Coras, Katja Kobow, David M Herrera, Antonio Del Barrio, Hans Atli Dahl, Isabel Del Pino, Stéphanie Baulac, Ingmar Blumcke, Rikke S Møller, Antonio Gil-Nagel |
X Demographics
The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 11 | 35% |
| United States | 4 | 13% |
| Denmark | 3 | 10% |
| United Kingdom | 2 | 6% |
| France | 2 | 6% |
| Saudi Arabia | 1 | 3% |
| Chile | 1 | 3% |
| Germany | 1 | 3% |
| Unknown | 6 | 19% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 61% |
| Scientists | 8 | 26% |
| Practitioners (doctors, other healthcare professionals) | 4 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 20 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 15% |
| Unspecified | 2 | 10% |
| Other | 2 | 10% |
| Student > Ph. D. Student | 2 | 10% |
| Student > Doctoral Student | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 8 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 5 | 25% |
| Unspecified | 2 | 10% |
| Medicine and Dentistry | 2 | 10% |
| Agricultural and Biological Sciences | 1 | 5% |
| Biochemistry, Genetics and Molecular Biology | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 9 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2023.
All research outputs
#1,604,212
of 25,420,980 outputs
Outputs from Neurotherapeutics
#128
of 1,308 outputs
Outputs of similar age
#31,089
of 385,022 outputs
Outputs of similar age from Neurotherapeutics
#2
of 18 outputs
Altmetric has tracked 25,420,980 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 385,022 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.